Collin College Cardiac Drugs Practice Test

Procainamide is a class IA antiarrhythmic medication commonly used to treat ventricular arrhythmias. A key consideration when using Procainamide is the requirement to monitor renal function. This is crucial because Procainamide is primarily eliminated by the kidneys, and in patients with compromised renal function, the drug can accumulate in the system, leading to increased toxicity and potential adverse effects.

Monitoring renal function ensures that the dosage can be adjusted appropriately to avoid the risk of higher plasma concentrations, which can result in side effects such as hypotension, decreased cardiac output, or even development of drug-induced lupus-like syndrome with prolonged use. Therefore, regular assessment of renal function is essential to safely manage the administration of Procainamide and to optimize its therapeutic effects while minimizing potential risks.